Biobillionair Tuesday, 02/12/19 09:10:46 AM Re: Biobillionair post# 175777 0 Post # of 177264 I'm guessing the following is going to be negotiated within Amarin's First Amendment rights regarding Vascepa promotion: Anti-inflammatory effects in diseases such as: cancer, asthma, rheumatoid arthritis, osteoporosis, dry eye disease, and age-related macular degeneration Quote: anti-inflammatory effects in diseases such as cancer, asthma, rheumatoid arthritis, osteoporosis, dry eye disease, age-related macular degeneration, coronary heart disease and sepsis. Likely the reason why the FDA cherry picked out the above quotes.... Again link to letter:https://www.fda.gov/ICECI/EnforcementActions/WarningLetters/ucm630564.htm Thanks to Baa and ST BB I do not pump Amarin stock. I am not an Amarin cheerleader. If I see something I don't like I make it known. Patients come first, always!!!